Runfa Bao

2.4k total citations
39 papers, 1.3k citations indexed

About

Runfa Bao is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Runfa Bao has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Surgery and 15 papers in Cancer Research. Recurrent topics in Runfa Bao's work include Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer, Lipids, and Metabolism (5 papers). Runfa Bao is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer, Lipids, and Metabolism (5 papers). Runfa Bao collaborates with scholars based in China, India and Hong Kong. Runfa Bao's co-authors include Yijun Shu, Yingbin Liu, Maolan Li, Xiangsong Wu, Hao Weng, Yang Cao, Jiasheng Mu, Qian Ding, Xuan Wang and Yunping Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Death and Differentiation and Molecules.

In The Last Decade

Runfa Bao

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runfa Bao China 22 815 510 342 310 150 39 1.3k
Yijun Shu China 24 923 1.1× 546 1.1× 374 1.1× 328 1.1× 172 1.1× 53 1.4k
Jiasheng Mu China 24 813 1.0× 453 0.9× 411 1.2× 386 1.2× 276 1.8× 37 1.5k
Wenlong Zhai China 18 765 0.9× 450 0.9× 224 0.7× 216 0.7× 162 1.1× 59 1.2k
Chengjian Shi China 15 534 0.7× 294 0.6× 523 1.5× 287 0.9× 194 1.3× 26 1.1k
Stina Garvin Sweden 17 734 0.9× 295 0.6× 633 1.9× 190 0.6× 114 0.8× 25 1.4k
Lie Yang China 22 720 0.9× 632 1.2× 405 1.2× 212 0.7× 180 1.2× 77 1.3k
Jianqun Ma China 22 894 1.1× 492 1.0× 275 0.8× 259 0.8× 324 2.2× 67 1.4k
Zheng Zhu China 20 834 1.0× 577 1.1× 440 1.3× 278 0.9× 378 2.5× 41 1.6k
Kun Wu China 19 838 1.0× 515 1.0× 249 0.7× 186 0.6× 121 0.8× 59 1.3k

Countries citing papers authored by Runfa Bao

Since Specialization
Citations

This map shows the geographic impact of Runfa Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runfa Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runfa Bao more than expected).

Fields of papers citing papers by Runfa Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runfa Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runfa Bao. The network helps show where Runfa Bao may publish in the future.

Co-authorship network of co-authors of Runfa Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Runfa Bao. A scholar is included among the top collaborators of Runfa Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runfa Bao. Runfa Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weng, Hao, Xiaoling Song, Yijun Shu, et al.. (2023). Preoperative pancreatic CT value is related to pancreatic fistula after pancreaticoduodenectomy: a retrospective study. Gland Surgery. 12(2). 243–251. 1 indexed citations
2.
Liu, Fa-tao, Wenguang Wu, Xuechuan Li, et al.. (2023). Case report: A de novo ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparib. Frontiers in Oncology. 13. 1078388–1078388.
3.
Jiang, Chengkai, Yang Li, Yongsheng Li, et al.. (2022). Fibrinogen promotes gallbladder cancer cell metastasis and extravasation by inducing ICAM1 expression. Medical Oncology. 40(1). 10–10. 19 indexed citations
4.
Zou, Lu, Yang Yang, Weijian Li, et al.. (2022). tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L. Cellular & Molecular Biology Letters. 27(1). 99–99. 15 indexed citations
5.
Bian, Rui, Wei Dang, Xiaoling Song, et al.. (2021). Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis. International Journal of Biological Sciences. 17(9). 2167–2180. 19 indexed citations
6.
Bao, Runfa, et al.. (2019). Clinical efficacy of GEMOX regimen combined with targeted therapy for advanced gallbladder cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 18(2). 140–145. 1 indexed citations
7.
Mei, Jiawei, Ziyi Yang, Honggang Xiang, et al.. (2019). MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1. BMC Cancer. 19(1). 740–740. 29 indexed citations
8.
Shu, Yijun, Runfa Bao, Lin Jiang, et al.. (2017). MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway. Cell Death and Differentiation. 24(3). 445–457. 72 indexed citations
9.
Zhao, Shuai, Yang Cao, Shibo Liu, et al.. (2016). The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR. Journal of Experimental & Clinical Cancer Research. 35(1). 97–97. 28 indexed citations
10.
Cao, Yang, Haibin Liang, Fei Zhang, et al.. (2016). Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 68–68. 43 indexed citations
11.
Shu, Yijun, Lin Jiang, Runfa Bao, et al.. (2015). Expression of miR-29c-5p in gallbladder cancer tissue and its clinical significance. Zhonghua putong waike zazhi. 30(9). 715–718. 1 indexed citations
12.
Weng, Hao, Maolan Li, Xiangsong Wu, et al.. (2015). Zinc finger X-chromosomal protein (ZFX) is a significant prognostic indicator and promotes cellular malignant potential in gallbladder cancer. Cancer Biology & Therapy. 16(10). 1462–1470. 27 indexed citations
13.
Li, Huai-Feng, Xuan Wang, Shanshan Xiang, et al.. (2015). Oleanolic acid induces mitochondrial-dependent apoptosis and G0/G1 phase arrest in gallbladder cancer cells. Drug Design Development and Therapy. 9. 3017–3017. 35 indexed citations
14.
Weng, Hao, Yijun Shu, Runfa Bao, et al.. (2014). Preoperative pancreas plain scan CT value for the evaluation of the risk of postoperative pancreatic fistula. Zhonghua putong waike zazhi. 29(1). 21–24. 1 indexed citations
15.
Bao, Runfa, Qian Ding, Yang Cao, et al.. (2014). Baicalin Induces Apoptosis of Gallbladder Carcinoma Cells in vitro via a Mitochondrial-Mediated Pathway and Suppresses Tumor Growth in vivo. Anti-Cancer Agents in Medicinal Chemistry. 14(8). 1136–1145. 21 indexed citations
16.
Bao, Runfa, Yijun Shu, Xiangsong Wu, et al.. (2014). Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway. BMC Cancer. 14(1). 217–217. 77 indexed citations
18.
Li, Maolan, Wenguang Wu, Jiasheng Mu, et al.. (2013). The role of prophylactic transpapillary pancreatic stenting in distal pancreatectomy: a meta-analysis. Frontiers of Medicine. 7(4). 499–505. 11 indexed citations
19.
Wu, Xiangsong, Liubin Shi, Maolan Li, et al.. (2013). Evaluation of Two Inflammation-Based Prognostic Scores in Patients with Resectable Gallbladder Carcinoma. Annals of Surgical Oncology. 21(2). 449–457. 79 indexed citations
20.
Tan, Zhujun, Maolan Li, Xiangsong Wu, et al.. (2013). Regulation of cell proliferation and migration in gallbladder cancer by zinc finger X-chromosomal protein. Gene. 528(2). 261–266. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026